Rhythm Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters??? Option To Purchase Additional Shares
BOSTON, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for treatment of rare genetic deficiencies that…